Search Results - Ken Nally
- Showing 1 - 5 results of 5
-
1
-
2
Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise by Brian Healey Bird, Ken Nally, Karine Ronan, Gerard Clarke, Sylvie Amu, Ana S. Almeida, Richard Flavin, Stephen Finn
Published in Diagnostics (2022-01-01)Get full text
Article -
3
Bifidobacterium breve Exopolysaccharide Blocks Dendritic Cell Maturation and Activation of CD4+ T Cells by Ana Hickey, Ana Hickey, Panagiota Stamou, Sreeram Udayan, Sreeram Udayan, Ana Ramón-Vázquez, Maria Esteban-Torres, Maria Esteban-Torres, Francesca Bottacini, Francesca Bottacini, Jerzy Adam Woznicki, Owen Hughes, Silvia Melgar, Marco Ventura, Douwe Van Sinderen, Douwe Van Sinderen, Valerio Rossini, Ken Nally, Ken Nally
Published in Frontiers in Microbiology (2021-06-01)Get full text
Article -
4
An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors by Raminder Singh, Valerio Rossini, Stephen R. Stockdale, Gonzalo Saiz-Gonzalo, Naomi Hanrahan, Tanya D’ Souza, Adam Clooney, Lorraine A. Draper, Colin Hill, Ken Nally, Fergus Shanahan, Stefan Andersson-Engels, Silvia Melgar
Published in Gut Microbes (2023-12-01)Get full text
Article -
5
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice by María A. Núñez-Sánchez, Florence M. Herisson, Jonathan M. Keane, Natalia García-González, Valerio Rossini, Jorge Pinhiero, Jack Daly, Milán Bustamante-Garrido, Cara M. Hueston, Shriram Patel, Nuria Canela, Pol Herrero, Marcus J. Claesson, Silvia Melgar, Ken Nally, Noel M. Caplice, Cormac G.M. Gahan
Published in Gut Microbes (2022-12-01)Get full text
Article